A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Monday, November 7 | 3-4 p.m. ET | Virtual As part of the NHGRI's Genomics and Health Disparities Lecture Series, Dr. Kullo will discuss his research on the genetic basis […]
Tuesday, November 8 | 9 am EST | Virtual This webinar will be presented by Dr. Segun Fatumo. The title of his talk is “Navigating Global Biobank Bias for Genomic […]
Monday, November 14 | 2-3:30 pm ET | Virtual Family health history is a risk factor for many common chronic diseases, such as cancer and heart disease. Knowing a patient’s […]
Tuesday, November 29-Friday, December 2 | 8-11:30 am ET | Virtual The theme of this year’s summit is: The Journey to Globally Accelerate Science, Diversity, and Global Health in Longitudinal […]
Friday, December 9 | 12-1 p.m. ET | Virtual Anya Prince, JD and Jean Cadigan, PhD will give a talk "Beyond the Medical: Genetic Testing for Social Traits." In traditional […]
Through a combination of plenaries, breakout, and poster sessions, the Annual Conference on the Science of Dissemination and Implementation in Health, co-hosted by the National Institutes of Health (NIH) and […]
Thursday, December 15 | 9 a.m. ET | Virtual This webinar will be presented by Dr. Peter Würtz and Dr. Jeffrey Barrett. The title of their talk is "Nightingale Biomarker […]
Friday, December 16 | 1-2 pm ET (12-1 pm CT) | Virtual The University of Minnesota College of Pharmacy invites all actively practicing clinicians to join their Pharmacogenomics (PGx) ECHO […]
Thursday, January 5 | 2-3 p.m. ET | Virtual and In-Person The Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating […]
Thursday, January 12 | 12-1 p.m. ET | Virtual The Duke Precision Medicine Program Forum Series features speakers from Duke and beyond working on innovative research in clinical, translational, and […]
GMKB